Bayer Aktiengesellschaft (FRA:BAYN)
Germany · Delayed Price · Currency is EUR | Market Cap | 26.77B |
| Revenue (ttm) | 46.17B |
| Net Income (ttm) | -3.42B |
| Shares Out | n/a |
| EPS (ttm) | -3.48 |
| PE Ratio | n/a |
| Forward PE | 5.77 |
| Dividend | 0.11 (0.40%) |
| Ex-Dividend Date | Apr 28, 2025 |
| Volume | 1,554,241 |
| Average Volume | 4,500 |
| Open | 26.90 |
| Previous Close | 27.25 |
| Day's Range | 26.57 - 27.38 |
| 52-Week Range | 18.50 - 31.01 |
| Beta | n/a |
| RSI | 46.52 |
| Earnings Date | Nov 12, 2025 |
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin... [Read more]
Financial Performance
In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.
Financial StatementsNews
Bayer Canada Announces New Distribution Partnership for ADALAT® XL® (nifedipine extended-release tablets) 30 mg Tablets in Canada
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Bayer Canada is pleased to announce a new partnership with Mint Pharmaceuticals Inc. for the distribution of ADALAT® XL® 30 mg tablets1 in Canada. This strategic...
Bayer to Highlight New Data for KERENDIA® (finerenone) at Heart Failure Society of America (HFSA) Annual Scientific Meeting 2025
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today that data from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented at the Heart Failure Society of America (...
Focus: Parkinson's disease at forefront of Bayer bet on cell and gene therapies
Bayer's pioneering cell and gene therapies for Parkinson's disease are at the forefront of an exciting but risky test of CEO Bill Anderson's development credentials as patent expiries on blockbuster d...
Shilpa Medicare shares jump over 4% as EMA grants nod for Rivaroxaban Orodispersible Films
Shares of Shilpa Medicare Limited surged 4.22% on Tuesday, September 23, trading at ₹853.00 on the NSE. The company’s market capitalization stood at ₹83.42 billion. The rally came after the pharma com...
Bayer CEO: overhaul is leading to pharma pipeline boost
Bayer Chief Executive Bill Anderson said the company is making "remarkable progress" in overcoming longstanding challenges, including a weak drug development pipeline, after an internal management ove...
Bayer moves Parkinson's cell therapy into Phase III trial
Bayer has started the third phase of human testing of an experimental stem cell therapy for Parkinson's disease, with future results potentially underpinning a request for regulatory approval, the com...
Bayer First Company to Advance Cell Therapy as Well as Gene Therapy Against Parkinson's Disease
BERLIN--(BUSINESS WIRE)--Bayer announced today progress for two potential therapies against Parkinson's disease (PD). A first participant received randomized treatment in the pivotal Phase III clinica...
Irelands pharma sector is world class, but why dont we have a Novo Nordisk to take our success to the next level?
Denmark has Novo Nordisk, France has Sanofi, Switzerland boasts both Roche and Novartis, while Germany has Bayer. Its a somewhat troubled relationship, but Britain has AstraZeneca.
Expert with Bayer Discusses the U.S. Launch of Aspirina Families with YourUpdateTV
Bayer's Aspirina – the #1 Pain Relief Option in Mexico – is Now Available in the U.S., Providing a Familiar and Effective Pain Relief Option to Hispanic Communities Bayer's Aspirina – the #1 Pain Reli...
Bayer project provides sports gear to kids
Bayer Thai has organised "Ronstar for Thai Kids" to provide sports equipment to farmers' children in northern and northeastern provinces.
10 Years of Supporting Rural America: Bayer and Luke Bryan Team Up with Feeding America to Tackle Hunger with “Take Care, Now” Campaign
Bayer today announced a milestone in its Take Care, Now campaign with country superstar and five-time Entertainer of the Year, Luke Bryan, and Feeding America, the nation’s largest hunger-relief organ...
10 Years of Supporting Rural America: Bayer and Luke Bryan Team Up with Feeding America® to Tackle Hunger with “Take Care, Now” Campaign
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced a milestone in its Take Care, Now campaign with country superstar and five-time Entertainer of the Year, Luke Bryan, and Feeding America®, the na...
Tata Elxsi inaugurates ‘Bayer Development Centre in Radiology’ at Pune, India
Tata Elxsi, a leading global player in design and technology services, has announced the inauguration of the Bayer Development Centre in Radiology at its Pune facility. The centre will focus on the co...
EQS-PVR: Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: Bayer Aktiengesellschaft Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Euro...
Bayer's E.L.Y. Wins “AI-based AgTech Solution of the Year” In 2025 AgTech Breakthrough Awards Program
Annual Awards Program Recognizes Innovation in Agricultural & Food Technologies Around the Globe Annual Awards Program Recognizes Innovation in Agricultural & Food Technologies Around the Globe
Bayer reaches settlement in PCB exposure lawsuits from Seattle-area school
Bayer settles Sky Valley cases over chemical PCB
Bayer said on Monday its Monsanto unit reached agreements in principle with more than 200 plaintiffs to resolve the so-called Sky Valley Education Center product liability cases related to the chemica...
Bayer Aspirin Introduces Aspirina to the U.S. Pain Market
Bayer’s Aspirina, the #1 pain relief option in Mexico1, is now available for purchase in the United States, bringing a well-known brand to the Hispanic community. With a deep commitment to Hispanic co...
Bayer® Aspirin Introduces Aspirina to the U.S. Pain Market
WHIPPANY, N.J.--(BUSINESS WIRE)-- #consumerhealth--Bayer's Aspirina, the #1 pain relief option in Mexico1, is now available for purchase in the United States, bringing a well-known brand to the Hispan...
LumenHaus Powers Bayer 04 Leverkusen as Official Premium Partner for 2025/26 Season
LEVERKUSEN, Germany, Aug. 15, 2025 (GLOBE NEWSWIRE) -- LumenHaus, Germany's forefront innovator in smart home energy solutions, has officially signed as an Official Premium Partner of Bayer 04 Leverku...
Why are Indoco Remedies shares up 2% today? Explained
Indoco Remedies Ltd shares climbed over 2% to ₹299.30 in morning trade on Tuesday after the company announced it has received final approval from the US Food and Drug Administration (USFDA) for its Ab...
Bayer and Kumquat Biosciences partner to develop cancer treatment
Bayer and Kumquat Biosciences Enter Global Exclusive License and Collaboration in Precision Oncology
BERLIN & SAN DIEGO--(BUSINESS WIRE)--Bayer and Kumquat Biosciences Inc., a clinical-stage biotech company founded by pioneers of the KRAS pathway, today announced that they have entered into an exclus...
Bayer inks $1.3 billion deal with Kumquat Biosciences for cancer drug development
Bayer adds cancer drug candidate to portfolio with $1.3-billion Kumquat deal
German pharmaceutical group Bayer announced on Tuesday a deal worth up to $1.3 billion with Kumquat Biosciences to develop the U.S.-based oncology specialist's potential new cancer drug.